Comparability of serum prostate-specific antigen measurement between the Hybritech Tandem-R and Abbott AxSYM assays
- 1 September 1998
- Vol. 52 (3) , 467-469
- https://doi.org/10.1016/s0090-4295(98)00210-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- DEFINING THE IDEAL TUMOR MARKER FOR PROSTATE CANCERUrologic Clinics of North America, 1997
- PROSTATE-SPECIFIC ANTIGEN AS A SCREENING TEST FOR PROSTATE CANCERUrologic Clinics of North America, 1997
- Comparison between Equimolar- and Skewed-Response Assays of Prostate Specific Antigen: Is There an Influence on the Clinical Significance When Measuring Total Serum Prostate Specific Antigen?Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1996
- The Clinical Usefulness of Prostate Specific Antigen: Update 1994Journal of Urology, 1994
- Comparability of the tandem-R andIMx assays for the measurement of serum prostate-specific antigenUrology, 1994
- Assay for prostate specific antigen (PSA): Problems and possible solutionsJournal of Clinical Laboratory Analysis, 1994
- Standardization of immunoassays for prostate-specific antigen. A problem of prostate-specific antigen complexation or a problem of assay design?Cancer, 1993
- Comparison of a Polyclonal and Monoclonal Immunoassay for PSA: Need for an International Antigen StandardJournal of Urology, 1990